Xencor (XNCR) Enterprise Value Growth (1y) (2014 - 2026)
Xencor (XNCR) Enterprise Value Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - |
| 2 | Nanobiotix | 1,911.11 Bn | 1,911.05 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 467.81 Bn | 463.02 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.92 Bn | 115.68 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.28 Bn | 61.53 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.88 Bn | 62.88 Bn | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Xencor | 1.50 Bn | 1.11 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -334.10% |
| Dec 31, 2025 | 4.01% |
| Sep 30, 2025 | 75.90% |
| Jun 30, 2025 | -563.28% |
| Mar 31, 2025 | -16.65% |
| Dec 31, 2024 | 17.73% |
| Sep 30, 2024 | -0.31% |
| Jun 30, 2024 | 18.58% |
| Mar 31, 2024 | 32.29% |
| Dec 31, 2023 | -471.92% |
| Sep 30, 2023 | -448.76% |
| Jun 30, 2023 | 2.08% |
| Mar 31, 2023 | -0.36% |
| Dec 31, 2022 | 46.56% |
| Sep 30, 2022 | 4.44% |
| Jun 30, 2022 | 52.63% |
| Mar 31, 2022 | 79.54% |
| Dec 31, 2021 | -6.81% |
| Sep 30, 2021 | -39.86% |
| Jun 30, 2021 | -43.63% |